Hebei collection results publicity: nitrobenzene 1 minute 2 cents 3 metformin 4 minutes 3...

The price of generic drugs out of a new low
a new round of national collection has not yet officially started, a number of generic drugs have once again refreshed the floor price - nitrobenzene (10mg) single piece 1 minute 2 minutes 3, Nizantiflat (10mg) single piece 1 minute 9 cents 7, Greburn tablets (2.5mg) single 1 minute 9 cents 8December 11, Hebei Province medical medicine equipment centralized procurement center will be selected 13 kinds of hypertension diabetes outpatient drugs for publicity13 selected varieties, through the consistency evaluation of 4 varieties of 5 product rules, respectively, catopli tablets, metformin hydrochloride tablets, gremetain tablets, Acapo sugar tabletsis worth noting that, among them, the Katopli tablets are the first round of quantity procurement of abandoned varieties, and hydrochloric acid metformin tablets, gremetain tablets, Acapo sugar tablets are a new round of band procurement varieties, and some of the winning enterprises have passed a consistent evaluation, respectively, stone pharmaceutical group European-Italian Pharmaceuticals, Beijing Beilu Pharmaceuticals, Hangzhou China-China East China Pharmaceuticalsfrom the results of the proposed bid, Hangzhou China-U.SEast China Pharmaceutical's Akapo sugar tablets (50mg), with a single tablet of 6 gross 1 price, and the maximum price, each tablet by 7 cents; 5g), a single piece 4 minutes 3, on the basis of the maximum price (1 gross / tablet), a reduction of 58%;according to the provisions, the declared price is the actual supply price of the declared enterprise, including taxes, distribution fees and other expenseshas not been evaluated pharmaceutical enterprises, to join the competition
there are 9 varieties by the drug companies that have not been consistent evaluation, a single tablet but more than 1 point of nitrobenzene flat tablets is selected by Shandong Luxi pharmaceutical industry, did not pass the consistency evaluationaccording to the provisions of the Hebei Province Drug Mining Center, under the same common name through the consistency evaluation of less than 3 pharmaceutical production enterprises, the drug that has not passed the consistency evaluation, if it meets the requirements, can confirm the selection, but the proposed price needs to be lower than through the consistency evaluation of more than 20% of drugs, otherwise no longer determineda domestic enterprise's promotion manager Wu Xiaoxuan said to Cypress Blue, not consistent evaluation of pharmaceutical companies must have a strong price reduction momentum, because they themselves have not sold a good price - according to the relevant state regulations, the price of drugs that have not been consistent evaluation of drugs must not be higher than the consistency evaluation of drugs, and if the same generic drug over the consistency evaluation of drugs full of three, will not be the procurement of products not consistent evaluation of pharmaceutical companiesalso pointed out that if the same generic drug has a consistent evaluation of pharmaceutical companies, still let the drug has not been consistent evaluation of the winning bid, there is no special reason is not appropriate, because the current situation is to make the drug high quality and low price, in any case, quality should be in the first placeof course, if the breed does not pass a consistency evaluation, in order to reduce the burden of ordinary people and health care, in the absence of better choice, the procurement of products that have not been consistent evaluation is understandable, he addedthe national collection price will only be lower
in fact, in addition to Hebei, November 26, Jiangxi Provincial People's Government issued "Jiangxi Province drug belt procurement and use of the implementation plan" also proposed that, never through the quality and efficacy consistency evaluation of generic drugs corresponding to generic drugs, the selection of some of the large clinical dosage, high procurement amount and more competitive drugs, the organization of the implementation of the collection of goods, Guo Taihong, former president of the Zhejiang Pharmaceutical Industry Association, told SaiPerblue, "I think there is still too little evaluation of drugs." In the future, more drugs have been evaluated, and the selection of drugs that have not been evaluated will gradually decrease." however, under the rules of national collection, consistency evaluation should remain the bottom line requirement - on November 27, the State Organization of Drug Central Procurement and Use of Joint Procurement Office issued a document, the document stipulates that the selection scope of the procurement varieties is, as of October 31, 2019, the original research, reference preparations, over-consistency evaluation varieties of more than three centralized procurement the provincial collection of Hebei Province, pharmaceutical companies reported low prices, why cause concern? Because this will affect the price of a new round of national collection (through consistency evaluation of drugs), industry experts said to Cypress Blue indeed, Hebei Province Drug Mining Center will definitely give the selected enterprises under the general name of the variety of the province's total market share - only Hebei Province's procurement volume, the above three pharmaceutical companies on the choice of low-cost selection, in the next national collection, the competitiveness of these pharmaceutical companies and the determination to choose should not be underestimated, they took the lead in the offer also to a certain extent to preview a new round of national drug collection war situation Hebei Province, however, also stipulated that "if the centralized procurement of drugs by the State Organization involves the centralized procurement of drugs, in accordance with the requirements of the State." In other words, the final price of high probability of national collection will be lower, when Hebei Province's current winning price may still fall further for generic drugs constantly refresh the floor price, Guo Taihong said to Cypress Blue, now the price of centralized procurement of drugs, are the enterprise's own price, is not the government department suing the price, so, the price is lower, is also the independent operation of the enterprise, is the result of accurate calculation of enterprises, there is no excuse.